ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ITOS iTeos Therapeutics Inc

11.66
0.17 (1.48%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
iTeos Therapeutics Inc ITOS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.17 1.48% 11.66 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.72 11.51 11.92 11.66 11.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/4/202415:30GLOBEiTeos Presents EOS-984 Preclinical Data Demonstrating..
08/3/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202419:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202406:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202406:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202406:01GLOBEiTeos Appoints Oncology Veteran Jill DeSimone to Its Board..
06/3/202406:00GLOBEiTeos Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202415:30GLOBEiTeos to Highlight Preclinical Data on First-In-Class..
01/3/202406:00GLOBEiTeos to Participate in Upcoming Investor Conferences
10/1/202416:00EDGAR2Form 8-K - Current report
08/1/202406:00GLOBEiTeos Announces 2024 Strategic Priorities and Anticipated..
03/1/202406:00GLOBEiTeos to Present at the 42nd Annual J.P. Morgan Healthcare..
07/12/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202319:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202319:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202315:11EDGAR2Form 8-K - Current report
21/11/202306:00GLOBEiTeos to Present at the Piper Sandler 35th Annual Healthcare..
07/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:00GLOBEiTeos Reports Third Quarter 2023 Financial Results and..
12/10/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:55PRNUSNCR Atleos Set to Join S&P SmallCap 600
06/9/202306:00GLOBEiTeos to Participate in Upcoming Investor Conferences
08/8/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:00GLOBEiTeos Reports Second Quarter 2023 Financial Results and..
10/5/202306:01GLOBEiTeos Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock